Browse Related Topics For:

Hatch-Waxman

59
Patents
37
Pharmaceutical
33
Generic Drugs
25
Pharmaceutical Patents
24
ANDA
23
FTC
23
Patent Litigation
22
SCOTUS
19
Patent Infringement
19
Reverse Payment Settlement Agreements
18
FTC v Actavis
18
Prescription Drugs
17
FDA
14
Pharmaceutical Manufacturers
10
Pay-For-Delay
8
Anti-Competitive
8
Antitrust Litigation
7
Settlement
6
Actavis Inc.
5
Biosimilars
5
BPCIA
5
Drug Manufacturers
5
Infringement
5
Inter Partes Review Proceedings
5
Patent Trial and Appeal Board
5
Popular
4
America Invents Act
4
Obviousness
4
Patent Reform
4
Personal Jurisdiction
4
Safe Harbors
3
AstraZeneca
3
Biologics
3
Claim Construction
3
Declaratory Judgments
3
Mylan Pharmaceuticals
3
Standard of Review
3
Watson Pharmaceuticals
2
Actavis
2
Apotex
2
Biotechnology
2
Cephalon
2
DaimlerChrysler v Bauman
2
De Novo Standard of Review
2
FDCA
2
Generic
2
GlaxoSmithKline
2
Jurisdiction
2
Manufacturers
2
Non-Practicing Entities
2
Preliminary Injunctions
2
Presumption of Validity
2
Prior Art
2
Reverse Payments
2
Subject Matter Jurisdiction
2
Teva Pharmaceuticals
2
Teva v Sandoz
1
Allergan Inc
1
Amgen
1
AMP v Myriad
1
Annual Reports
1
Appeals
1
Article III
1
Biofuel
1
Biogen Idec
1
Biologics Price Competition and Innovation Act of 2009
1
Biopharmaceutical
1
Bowman v Monsanto
1
Brand
1
Burden of Proof
1
Certiorari
1
Claim Preclusion
1
Classen Immunotherapies
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Coca Cola
1
Combination Products
1
Competition
1
Consideration
1
Corporate Counsel
1
Covered Business Method Proceedings
1
Crestor
1
Damages
1
Design Defects
1
Design Patent
1
Discovery
1
Discovery Schedule
1
Dismissals
1
DNA
1
Doctrine of Equivalents
1
Drug Approvals
1
Duty to Deal
1
eBay
1
Eli Lilly
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
Exemptions
1
Expert Testimony
1
Extrinsic Evidence
1
Failure To Warn
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
Forum
1
Fresenius
1
Genzyme
1
Hedge Funds
1
Human Genes
1
Injunctions
1
Innovation Act
1
Integra
1
Intellectual Property Litigation
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Inventions
1
Jazz Pharmaceuticals
1
Joinder
1
Lanham Act
1
Life Sciences
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Mayo v. Prometheus
1
Medicare Modernization Act
1
Merck
1
Minimum Contacts
1
Misrepresentation
1
Monsanto
1
Motion to Dismiss
1
Mutual Pharmaceuticals v Bartlett
1
Myriad
1
Noninfringement
1
Novartis
1
Orange Book
1
Par Pharmaceutical
1
Par/Paddock
1
Patent Applications
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Trolls
1
Patent-Eligible Subject Matter
1
Patent-in-Suit
1
Patentability Search
1
Pfizer
1
Pleadings
1
POM Wonderful
1
Preemption
1
Premarket Approval Applications
1
Price Manipulation
1
Prioritized Examination
1
Product Exclusivity
1
Product Hopping
1
Reissue Patents
1
Restraint of Trade
1
Reversal
1
Ripeness
1
Rosuvastatin
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Sandoz
1
Sandoz v Amgen
1
Sherman Act
1
Standard of Proof
1
Standing
1
Supplemental Examination
1
Takeda Pharmaceuticals
1
Unfair Competition
1
USPTO
1
Validity
1
Valuation
1
Vitiation Test
1
Written Descriptions